PharmEvo

CompanyPakistan

PharmEvo develops one asset, in phase 3 (BPM31510 in Parkinson's disease). Mostly supplement; based in Pakistan.

1
Asset
Furthest stage
Phase 3
4
Trials
0
Signals

Pipeline

1
  • BPM31510

    Supports mitochondrial electron transport and antioxidant defenses.

    Phase 3, Supplement, Parkinson's disease, glioblastoma (Phase 2)

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms1
  • Trials6
  • Signals4
  • Similar companies6

Intelligence